Therapy News and Research

RSS

CBT can be an effective first-line treatment for insomnia among individuals with alcohol use disorder

A study led by a University of Missouri School of Medicine researcher has established that cognitive behavioral therapy (CBT) is an effective first-line treatment for insomnia among individuals with alcohol use disorder, regardless of abstinence from alcohol.

12 Jul 2023

Psychedelic-based therapies poised to change the treatments for patients with PTSD

Psychedelic-based therapies are poised to change the treatments that psychiatrists can offer patients.

12 Jul 2023

2023 recipients of the Diversity in Lupus Research Awards announced

The Lupus Research Alliance is pleased to announce the 2023 recipients of the Career Development and Postdoctoral Awards to Promote Diversity in Lupus Research.

12 Jul 2023

Lecanemab: First disease-modifying therapy for Alzheimer's disease approved by FDA

On July 6, 2023, the U.S. Food and Drug Administration granted full approval to lecanemab, marketed as Leqembi, for the treatment of Alzheimer's disease.

12 Jul 2023

Cetuximab plus radiotherapy effective in treating locally advanced cutaneous squamous cell cancer

A new research paper was published in Oncotarget's Volume 14 on July 7, 2023, entitled, "Effectiveness and toxicity of cetuximab with concurrent RT in locally advanced cutaneous squamous cell skin cancer: a case series."

12 Jul 2023

Researchers receive $3.9 million grant to evaluate effects of e-cigarette flavors on smoking behaviors

A new $3.9 million grant from the U.S. Food and Drug Administration (FDA) will allow researchers with the Center for Tobacco Research at The Ohio State University Comprehensive Cancer Center to evaluate effects of e-cigarette flavors on the smoking behaviors of current adult smokers.

12 Jul 2023

Difficult transmembrane protein targets for therapeutic antibodies

In this interview, News-Medical talks to Sylvia Xie, product scientist at Sino Biological, about the ongoing emergence of transmembrane proteins as targets for therapeutic antibodies.

From Sino Biological Inc. 12 Jul 2023

UCSF's new pain clinic in Walnut Creek offers hope for children with chronic pain

Each year, too many kids in the East Bay suffer needlessly from pain related to long-term serious illness, including migraines, joint and abdominal pain, sickle cell anemia and more. A new UCSF Health pain clinic in Walnut Creek is opening to provide relief.

11 Jul 2023

Prescription stimulants safe for treating ADHD, study finds

Many parents whose kids take prescription stimulants like Ritalin to treat ADHD worry that it could lead to illicit drug use later.

11 Jul 2023

Imperial spinout NK:IO awarded £1.6M Innovate UK New Cancer Therapeutics grant for development of pioneering NK cell therapy

NK:IO, a leader in NK cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumors, today announced it has been awarded £1.6M in grant funding from Innovate UK’s New Cancer Therapeutics program.

From NK:IO Limited 11 Jul 2023

Muscle soothes mind: Exercise training can lower stress-related blood pressure responses

Researchers performed a meta-analysis to elucidate the effects of exercise training on stress-related blood pressure reactivity.

11 Jul 2023

The antibacterial properties of eucalyptus oil against two main oral disease pathogens

Researchers tested the efficacy of Eucalyptus oil again two bacteria responsible for dental caries.

11 Jul 2023

Could neutralizing SARS-CoV-2 monoclonal antibodies pre-exposure prophylaxis be cost-effective in a population at risk for severe COVID-19?

A recent study evaluated the cost-effectiveness of monoclonal antibodies as pre-exposure prophylaxis (PrEP) for COVID-19.

11 Jul 2023

New clinical trial seeks a regenerative pharmaceutical solution for meniscal tears

With support from Amplicore, a University of Cincinnati spinoff biopharmaceutical company, researchers at UC have begun a Department of Defense-funded clinical trial that seeks a regenerative pharmaceutical solution for meniscal tears.

10 Jul 2023

Phosphorothioate backbone modification enhances aptamer-drug conjugate for pancreatic cancer therapy

Pancreatic cancer is a complex and deadly solid tumor that poses significant challenges for both diagnosis and treatment.

10 Jul 2023

AMP releases consensus recommendations for CYP3A4 and CYP3A5 genotyping assays

The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP3A4 and CYP3A5 genotyping assays, promote standardization of testing across different laboratories, and improve patient care.

10 Jul 2023

High tumor monocyte content linked to better outcomes for esophageal cancer patients

A Ludwig Cancer Research study has discovered that the presence of relatively high numbers of immune cells known as monocytes in tumors is linked to better outcomes in esophageal cancer patients treated with a combination of chemotherapy and immunotherapy, or immunochemotherapy.

10 Jul 2023

Alcohol-related hepatitis hospitalizations increased dramatically during the pandemic

A boom in alcohol sales during the pandemic appears to have had dire consequences for some as hospital admissions for alcohol-related hepatitis, a life-threatening liver inflammation, increased dramatically, according to a study of national hospitalization data.

10 Jul 2023

Biomarkers in the brain could redefine mental health conditions

The study of biomarkers in the brain - powered by cutting-edge machine learning techniques - could redefine the way mental health conditions are categorized and diagnosed and lead to more effective, personalized treatments.

10 Jul 2023

New research sheds light on role of progesterone in breast cancer

A new research perspective was published in Oncotarget's Volume 14 on July 1, 2023, entitled, "Deciphering the mechanisms of action of progesterone in breast cancer."

10 Jul 2023

Therapy News and Research

CBT can be an effective first-line treatment for insomnia among individuals with alcohol use disorder

Psychedelic-based therapies poised to change the treatments for patients with PTSD

2023 recipients of the Diversity in Lupus Research Awards announced

Lecanemab: First disease-modifying therapy for Alzheimer's disease approved by FDA

Cetuximab plus radiotherapy effective in treating locally advanced cutaneous squamous cell cancer

Researchers receive $3.9 million grant to evaluate effects of e-cigarette flavors on smoking behaviors

Difficult transmembrane protein targets for therapeutic antibodies

UCSF's new pain clinic in Walnut Creek offers hope for children with chronic pain

Prescription stimulants safe for treating ADHD, study finds

Imperial spinout NK:IO awarded £1.6M Innovate UK New Cancer Therapeutics grant for development of pioneering NK cell therapy

Muscle soothes mind: Exercise training can lower stress-related blood pressure responses

The antibacterial properties of eucalyptus oil against two main oral disease pathogens

Could neutralizing SARS-CoV-2 monoclonal antibodies pre-exposure prophylaxis be cost-effective in a population at risk for severe COVID-19?

New clinical trial seeks a regenerative pharmaceutical solution for meniscal tears

Phosphorothioate backbone modification enhances aptamer-drug conjugate for pancreatic cancer therapy

AMP releases consensus recommendations for CYP3A4 and CYP3A5 genotyping assays

High tumor monocyte content linked to better outcomes for esophageal cancer patients

Alcohol-related hepatitis hospitalizations increased dramatically during the pandemic

Biomarkers in the brain could redefine mental health conditions

New research sheds light on role of progesterone in breast cancer

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News